Shanghai Kaibao Pharmaceutical Cash Flow Conversion Efficiency

Latest as of September 2025: 0.042x

Shanghai Kaibao Pharmaceutical cash flow conversion efficiency. Based on the latest financial reports, Shanghai Kaibao Pharmaceutical (300039) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥190.98 Million ≈ $27.95 Million USD) by net assets (CN¥4.55 Billion ≈ $665.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Kaibao Pharmaceutical (2006–2025)

Cash flow conversion efficiency of Shanghai Kaibao Pharmaceutical from 2006 to 2025. This chart illustrates how Shanghai Kaibao Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300039 stock price for real-time trading data and today's change.

Shanghai Kaibao Pharmaceutical Cash Flow Conversion Ratio Explained

Shanghai Kaibao Pharmaceutical cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Kaibao Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Kaibao Pharmaceutical ranked by their cash flow conversion efficiency. Also see market value of Shanghai Kaibao Pharmaceutical for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
SK Securities Co Ltd Preference Shares KO:001515	-0.132x
Fidus Investment Corp NASDAQ:FDUS	0.018x
Gujarat Narmada Valley Fertilizers and Chemicals Limited NSE:GNFC	0.034x
Collegium Pharmaceutical Inc NASDAQ:COLL	0.285x
Annexon Inc NASDAQ:ANNX	-0.258x
Scanfil Oyj HE:SCANFL	0.025x
SKF India Limited NSE:SKFINDIA	0.240x
Nobia AB ST:NOBI	-0.026x

Annual Cash Flow Conversion Efficiency for Shanghai Kaibao Pharmaceutical (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Kaibao Pharmaceutical from 2006 to 2025. Review 300039 FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.42 Billion ≈ $646.60 Million	CN¥230.74 Million ≈ $33.76 Million	0.052x	-23.19%
2024-12-31	CN¥4.10 Billion ≈ $600.40 Million	CN¥278.95 Million ≈ $40.82 Million	0.068x	-28.35%
2023-12-31	CN¥4.03 Billion ≈ $590.13 Million	CN¥382.66 Million ≈ $56.00 Million	0.095x	-5.19%
2022-12-31	CN¥3.76 Billion ≈ $550.36 Million	CN¥376.42 Million ≈ $55.08 Million	0.100x	+141.71%
2021-12-31	CN¥3.04 Billion ≈ $445.57 Million	CN¥126.08 Million ≈ $18.45 Million	0.041x	-57.41%
2020-12-31	CN¥2.58 Billion ≈ $377.29 Million	CN¥250.65 Million ≈ $36.68 Million	0.097x	-25.23%
2019-12-31	CN¥2.57 Billion ≈ $376.00 Million	CN¥334.09 Million ≈ $48.89 Million	0.130x	+23.16%
2018-12-31	CN¥2.49 Billion ≈ $363.65 Million	CN¥262.36 Million ≈ $38.39 Million	0.106x	+1.62%
2017-12-31	CN¥2.37 Billion ≈ $346.14 Million	CN¥245.76 Million ≈ $35.96 Million	0.104x	-27.40%
2016-12-31	CN¥2.20 Billion ≈ $321.97 Million	CN¥314.88 Million ≈ $46.08 Million	0.143x	-12.25%
2015-12-31	CN¥2.01 Billion ≈ $293.47 Million	CN¥327.08 Million ≈ $47.86 Million	0.163x	+8.85%
2014-12-31	CN¥1.88 Billion ≈ $275.78 Million	CN¥282.38 Million ≈ $41.32 Million	0.150x	-10.95%
2013-12-31	CN¥1.61 Billion ≈ $235.02 Million	CN¥270.23 Million ≈ $39.54 Million	0.168x	-1.89%
2012-12-31	CN¥1.42 Billion ≈ $207.61 Million	CN¥243.32 Million ≈ $35.61 Million	0.171x	+132.79%
2011-12-31	CN¥1.33 Billion ≈ $195.27 Million	CN¥98.31 Million ≈ $14.39 Million	0.074x	+360.54%
2010-12-31	CN¥1.24 Billion ≈ $181.01 Million	CN¥19.79 Million ≈ $2.90 Million	0.016x	-65.23%
2009-12-31	CN¥1.15 Billion ≈ $167.72 Million	CN¥52.74 Million ≈ $7.72 Million	0.046x	-68.76%
2008-12-31	CN¥126.92 Million ≈ $18.57 Million	CN¥18.70 Million ≈ $2.74 Million	0.147x	-51.29%
2007-12-31	CN¥76.96 Million ≈ $11.26 Million	CN¥23.27 Million ≈ $3.41 Million	0.302x	-42.84%
2006-12-31	CN¥37.24 Million ≈ $5.45 Million	CN¥19.70 Million ≈ $2.88 Million	0.529x	--

About Shanghai Kaibao Pharmaceutical

SHE:300039 China Drug Manufacturers - Specialty & Generic

Market Cap

$746.95 Million

CN¥5.10 Billion CNY

Market Cap Rank

#9925 Global

#2552 in China

Share Price

CN¥4.88

Change (1 day)

+1.24%

52-Week Range

CN¥4.18 - CN¥6.66

All Time High

CN¥12.44